Results 221 to 230 of about 14,163 (275)
ESC Heart Failure, Volume 12, Issue 3, Page 2087-2097, June 2025.Abstract Aims Sodium‐glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i) have demonstrated effectiveness in reducing cardiovascular death and heart failure hospitalization (HFH). However, the efficacy and safety of SGLT2 inhibitors in elderly patients with poor general status, such as very low bodyweight or low nutritional status, who are not included ...
Kenji Nakano +15 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 2113-2124, June 2025.The prognostic impact of the muscle parameters gait speed, handgrip strength and appendicular skeletal muscle index on cardiovascular outcomes was investigated. We prospectively analyzed a cohort of 205 heart failure patients with a median left ventricular ejection fraction of 37% and a median follow‐up of 4.7 years.
Vladimir Cejka +17 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 2125-2133, June 2025.Abstract Background Sodium glucose cotransporter 2 inhibitors (SGLT2i) represent one of the four pillars of heart failure (HF) pharmacological therapy. Objective The study aims to clarify SGLT2i antiarrhythmic effect on patients with HF with reduced ejection fraction (HFrEF) in terms of atrial and ventricular arrhythmias (AAs and VAs) reduction ...
Marco Valerio Mariani +17 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 2134-2147, June 2025.Non‐scaled Venn diagram of iron deficiency (ID) according to various definitions and associated outcomes. The prevalence of iron deficiency was high, irrespective of the definition applied. ID defined by TSAT <20% or serum iron <13 μmol/L, rather than the guideline definition, was associated with worse outcomes.
Xinqing Li +7 more
wiley +1 more source
Sex‐related pathophysiological mechanisms may be present before symptoms of HFpEF develop
ESC Heart Failure, Volume 12, Issue 3, Page 2387-2390, June 2025.Abstract Aims Understanding sex‐related cardiovascular differences in those with pre‐HFpEF (asymptomatic with normal ejection fraction, elevated natriuretic peptides and structural or functional heart disease) could help explain why females are more likely to develop symptomatic HFpEF compared with males.
B. Wong +6 more
wiley +1 more source
Editorial: Clearance Pathways for Amyloid-β. Significance for Alzheimer's Disease and Its Therapy
Frontiers in Aging Neuroscience, 2017 Roxana O. Carare
doaj +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 1620-1629, June 2025.Abstract Aims Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health‐related quality of life (QoL) at Day 7 in both the overall population and in patients with baseline interleukin 6 > 13 pg/mL.
Matteo Pagnesi +21 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 2166-2176, June 2025.Abstract Aims To analyse the predictive value of advanced markers of right ventricular (RV) function and RV‐pulmonary arterial (PA) coupling in forecasting long‐term left ventricular (LV) improvement in de novo heart failure with reduced ejection fraction (HFrEF).
Aiste Monika Jakstaite +10 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 3, Page 2190-2199, June 2025.In this retrospective, observational study of a real‐life cohort of patients with heart failure with reduced ejection fraction, long‐term survival was improved in patients who achieved sustained reverse remodeling. Greater increases in ejection fraction (EF) and reductions in left ventricular end‐systolic diameter at the time of EF recovery, greater ...
Silas Ramos Furquim +13 more
wiley +1 more source